72821-79-5Relevant articles and documents
Synthesis of European pharmacopoeial impurities A, B, C, and D of cabergoline
Wagger, Jernej,Pozes, Aljaz,Pozgan, Franc
, p. 23146 - 23156 (2013/11/19)
For the use of analytics, European pharmacopoeial impurities A, B, C, and D of cabergoline were synthesized. Ergocryptine was chosen as a starting material and synthesis was accomplished via two approaches, different in length and stereochemical outcome. A longer, indirect approach was realized through otherwise problematic oxidations of the 9,10-dihidrolysergol derivative, to the corresponding aldehyde and carboxylic acid. This was achieved by the use of activated DMSO and a Pinnick oxidation sequence. All four synthesized impurities are used as analytical standards in cabergoline manufacturing processes.
New and efficient process for the preperation of cabergoline and its intermediates
-
Page/Page column 13, (2008/12/08)
This invention relates to a new and efficient process for the production of dopamine agonists such as Cabergoline and the intermediates thereof.
Antihypertensive ergolinepropionamides
Bernardi,Bosisio,Mantegani,Sapini,Temperilli,Salvati,di Salle,Arcari,Bianchi
, p. 1094 - 1098 (2007/10/02)
The synthesis and the antihypertensive activity in rats of a series of 6-methylergolin-8β-yl-propionic acid derivatives are reported. The prolactin lowering activity (nidation inhibition test) in rats and the acute toxicity in mice were also studied as a measure of the specificity and safety of the potential antihypertensive compounds. From the structure-activity considerations reported here it is clear how modifications at the C8 side chain can improve the selectivity of the antihypertensive effects, whilst introducing substituents in other positions of the ergoline skeleton afforded unfavourable results in this respect. Compound 5, namely 2(R,S)-cyano-3-(6-methylergolin-8β-yl)-propionamide, emerged as the most interesting antihypertensive derivative.